Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Lung immune cells can be trained to better fight infections after a virus.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

No link found between Coxsackie viruses and pemphigus.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

New drug uses show promise but need more research.

COVID-19 can cause various skin issues, like rashes and hair loss, which help in early diagnosis.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19 can cause or worsen skin conditions and might show early signs of infection.

COVID-19 can cause different skin issues, including rashes and hair loss.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Allergic cats with yeast overgrowth improved with antifungal treatment.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

Japanese researchers created new hair follicles from human cells that grew hair when put into mice, and other findings showed a link between eye disease severity and corneal thickness, gene mutations affecting hearing and touch, and the safety of the shingles vaccine for adults over 50.

Elderly people, especially with chronic conditions, are more at risk of severe COVID-19 complications and need preventive care and social support.

CMV infection increases the risk of GvHD after bone marrow transplants.

The study found specific skin and cell changes in patients with monkeypox, helping diagnose and understand the disease.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Viral reactivation is rare at the time of DRESS diagnosis in the U.S.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.